Based on the hypothesis that cancer acts as a chronic inflammatory condition with acute changes (or exacerbations) as a result of illness or chemotherapy administration, we had hypothesized that treatment with cancer-directed therapy would similarly result in higher GDF15 levels at 3 months compared to baseline. This evidence concerns the gene GDF15 and cancer.